These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22694023)

  • 1. Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes.
    Karkazis K; Jordan-Young R; Davis G; Camporesi S
    Am J Bioeth; 2012; 12(7):3-16. PubMed ID: 22694023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are the new policies on hyperandrogenism in elite female athletes really out of bounds? Response to "out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes".
    Bermon S; Ritzén M; Hirschberg AL; Murray TH
    Am J Bioeth; 2013; 13(5):63-5. PubMed ID: 23557056
    [No Abstract]   [Full Text] [Related]  

  • 3. New standards, same refrain: the IAAF's regulations on hyperandrogenism.
    Schultz J
    Am J Bioeth; 2012; 12(7):32-3. PubMed ID: 22694031
    [No Abstract]   [Full Text] [Related]  

  • 4. Reexamining rationales of "fairness": an athlete and insider's perspective on the new policies on hyperandrogenism in elite female athletes.
    Viloria HP; Martínez-Patino MJ
    Am J Bioeth; 2012; 12(7):17-9. PubMed ID: 22694024
    [No Abstract]   [Full Text] [Related]  

  • 5. Getting a leg up on the competition: the importance of osteology in elite athletics.
    Sutherland MB; Langer B; Wassersug R
    Am J Bioeth; 2012; 12(7):25-7. PubMed ID: 22694028
    [No Abstract]   [Full Text] [Related]  

  • 6. Gender transports: privileging the "natural" in gender testing debates for intersex and transgender athletes.
    Wahlert L; Fiester A
    Am J Bioeth; 2012; 12(7):19-21. PubMed ID: 22694025
    [No Abstract]   [Full Text] [Related]  

  • 7. The complexities of sport, gender, and drug testing.
    Sailors PR; Teetzel SJ; Weaving C
    Am J Bioeth; 2012; 12(7):23-5. PubMed ID: 22694027
    [No Abstract]   [Full Text] [Related]  

  • 8. Excellence, deviance, and gender: lessons from the XYY episode.
    Shani R; Barilan YM
    Am J Bioeth; 2012; 12(7):27-30. PubMed ID: 22694029
    [No Abstract]   [Full Text] [Related]  

  • 9. The Harrison Bergeron olympics.
    Karkazis K; Jordan-Young R
    Am J Bioeth; 2013; 13(5):66-9. PubMed ID: 23557057
    [No Abstract]   [Full Text] [Related]  

  • 10. Sport, sex segregation, and sex testing: critical reflections on this unjust marriage.
    Dworkin SL; Cooky C
    Am J Bioeth; 2012; 12(7):21-3. PubMed ID: 22694026
    [No Abstract]   [Full Text] [Related]  

  • 11. Sport is arbitrary, and that's ok.
    O'Connor D; Dasgupta I
    Am J Bioeth; 2012; 12(7):30-1. PubMed ID: 22694030
    [No Abstract]   [Full Text] [Related]  

  • 12. Outstanding performances during elite-standard short and middle-distance finals and the hyperandrogenism regulation-A detailed analysis of Caster Semenya's results.
    Ospina-Betancurt J; Zakynthinaki MS
    J Sports Sci; 2020 Mar; 38(6):703-709. PubMed ID: 32050847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new policy on hyperandrogenism in elite female athletes is not about "sex testing".
    Sánchez FJ; Martínez-Patiño MJ; Vilain E
    J Sex Res; 2013; 50(2):112-5. PubMed ID: 23320653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hurdling over sex? Sport, science, and equity.
    Ha NQ; Dworkin SL; Martínez-Patiño MJ; Rogol AD; Rosario V; Sánchez FJ; Wrynn A; Vilain E
    Arch Sex Behav; 2014 Aug; 43(6):1035-42. PubMed ID: 25085349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interconnected Histories of Endocrinology and Eligibility in Women's Sport.
    Rogol AD; Pieper LP
    Horm Res Paediatr; 2018; 90(4):213-220. PubMed ID: 30336491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender verification of female athletes.
    Elsas LJ; Ljungqvist A; Ferguson-Smith MA; Simpson JL; Genel M; Carlson AS; Ferris E; de la Chapelle A; Ehrhardt AA
    Genet Med; 2000; 2(4):249-54. PubMed ID: 11252710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperandrogenism and intersex controversies in women's olympics.
    Xavier NA; McGill JB
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3902-7. PubMed ID: 22990091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When does an advantage become unfair? Empirical and normative concerns in Semenya's case.
    Camporesi S
    J Med Ethics; 2019 Nov; 45(11):700-704. PubMed ID: 31527141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impossible "Choices": The Inherent Harms of Regulating Women's Testosterone in Sport.
    Karkazis K; Carpenter M
    J Bioeth Inq; 2018 Dec; 15(4):579-587. PubMed ID: 30117064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policing the boundaries of sex: a critical examination of gender verification and the Caster Semenya controversy.
    Cooky C; Dworkin SL
    J Sex Res; 2013; 50(2):103-11. PubMed ID: 23320629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.